Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays.

"Declarations Conflict of InterestThe views and conclusions presented in this paper are those of the authors and do not necessarily reflect the representative affiliation or company’s position on the subject.The authors are employed by their affiliated companies and have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Conflict of Interest The views and conclusions presented in this paper are those of the authors and do not necessarily reflect the representative affiliation or company’s position on the subject. The authors are employed by their affiliated companies and have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript."

"Funding This research was funded by BioAgilytix Labs and Lexeo Therapeutics."